DAPRODUSTAT FOR TREATMENT OF ANEMIA OF CKD IN PEDIATRIC PATIENTS: PROTOCOL FOR THE ASCEND-P TRIAL WITHIN A COHORT

WCN23-0672
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease Diagnosis, Classification and Progression
 
 
 
 
DAPRODUSTAT FOR TREATMENT OF ANEMIA OF CKD IN PEDIATRIC PATIENTS: PROTOCOL FOR THE ASCEND-P TRIAL WITHIN A COHORT
Hiemstra, T.(1)*;Vick, J.G.(2);Roberts, J.C.(3);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Gsk, Clinical Development, Stevenage, United Kingdom;(2)Gsk, Global Safety And Pharmacovigilance, North Carolina, United States;(3)Gsk, Clinical Sciences- R&D, Brentford- Middlesex, United Kingdom;
https://storage.unitedwebnetwork.com/files/1041/cf375e8cee89a263309da0b5e3a48387.pdf
 
if any